HUVEC cells treated with VEGF upregulated the expression of RhoJ in a VEGF concentration-dependent manner, indicating that RhoJ is an important downstream signaling molecule of VEGF in GBM angiogenesis. The gene discussed is VEGFA; the disease is glioblastoma.